Drug Profile


Alternative Names: Carboxyimamidate; N 137; NED 137; NSC 329514D; Plimar; Polima

Latest Information Update: 18 Oct 2000

Price : $50

At a glance

  • Originator Pharmacia Corporation; Wyeth
  • Class Cytostatics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 18 Oct 2000 No-Development-Reported for Cancer (Unknown route)
  • 05 Apr 2000 Monsanto has merged with Pharmacia & Upjohn to form Pharmacia Corporation
  • 23 Mar 1998 Profile reviewed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top